Top Markets
#1 Black Phoenix Black Phoenix +735.12%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.73%
#3 THORChain THORChain +24.59%
#4 THORChain Yield THORChain Yield +18.33%
#5 TENDIES TENDIES +17.08%
#6 MiL.k Alliance MiL.k Alliance +15.92%
#7 Biconomy Biconomy +15.76%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +14.58%
#9 Bless Bless +14.30%
#10 XPIN Network XPIN Network +13.95%
Coin of the day
Black Phoenix Black Phoenix
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Mirati Therapeutics, Inc. Mirati Therapeutics, Inc.

Mirati Therapeutics, Inc.

MRTX
शेयरों में रैंक #5115
Mirati Therapeutics, Inc. is a U.S.-based biotechnology firm operating at the... Mirati Therapeutics, Inc. is a U.S.-based biotechnology firm operating at the clinical stage, committed to identifying and developing treatments that target the genetic and immunological factors driving cancer progression. Its pipeline features MRTX849, a KRAS G12C inhibitor currently undergoing Phase 1/2 clinical trials for a range of malignancies, including non-small cell lung, colorectal, and pancreatic cancers. Additionally, the company is advancing Sitravatinib, an investigational broad-spectrum kinase inhibitor, which has reached Phase 3 clinical trials specifically for non-small cell lung cancer. Mirati also has a KRAS G12D inhibitor program in its preclinical development phase. The company has forged a collaboration and licensing agreement with BeiGene, Ltd. for the development, manufacturing, and commercialization of sitravatinib. Established in 1995, Mirati Therapeutics, Inc. maintains its headquarters in San Diego, California.
शेयर मूल्य
$58.70
अंतिम समन्वयन: 2024-01-23
मार्केट कैप
$2.98B
बदलाव (1 दिन)
0.00%
बदलाव (1 वर्ष)
0.00%
देश
US
व्यापार Mirati Therapeutics, Inc. (MRTX)

श्रेणी

Healthcare
Mirati Therapeutics, Inc. (MRTX) के लिए P/S अनुपात
2026 को P/S अनुपात TTM: 0
Mirati Therapeutics, Inc. की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी का वर्तमान P/S अनुपात (TTM) 0 है। 2026 के अंत में, कंपनी का P/S अनुपात 0 था।
Mirati Therapeutics, Inc. के लिए 2026 से 2026 तक P/S अनुपात का इतिहास
हर वर्ष के अंत में P/S अनुपात
वर्ष P/S अनुपात परिवर्तन
प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।
समान कंपनियों या प्रतिस्पर्धियों के लिए P/S अनुपात
कंपनी P/S अनुपात P/S अनुपात में अंतर देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH